Literature DB >> 19758763

Cognitive modulation of endocrine responses to CRH stimulation in healthy subjects.

James L Abelson1, Samir Khan, Elizabeth A Young, Israel Liberzon.   

Abstract

BACKGROUND: The hypothalamic-pituitary adrenal (HPA) axis is critical for biobehavioral adaptation to challenge and appears dysregulated in a range of psychiatric disorders. Its precise role in psychopathology remains unclear and discrepant and difficult to explain findings abound in the clinical literature. Basic research suggests this system is sensitive to psychosocial cues, but psychosocial milieu factors are rarely controlled or examined in psychiatric studies using biological probes of the HPA axis. To test the hypothesis that psychological factors might complicate HPA study results even in direct, pharmacological challenge paradigms, endocrine responses to corticotropin-releasing hormone (CRH) were examined under two different cognitive preparation conditions.
METHODS: Healthy subjects (n=32) received standard instructions or a cognitive intervention (CI) prior to injection with CRH and placebo, given on separate days in random order. The CI combined access to control over drug exposure with novelty reduction and coping enhancement. Blood samples were obtained via intravenous catheter before and after CRH.
RESULTS: Cognitive intervention reduced corticotropin (ACTH) levels, but only when CRH was given first (intervention by order interaction). It did not reduce cortisol response. The CI and visit (1st or 2nd) both impacted cortisol levels on placebo day.
CONCLUSIONS: Modifiable psychological factors may amplify or inhibit HPA axis activity in pharmacological activation paradigms, including CRH stimulation tests. The factors manipulated by the CI (novelty/familiarity, control and coping) may have particular salience to the HPA axis. Differential sensitivity to such factors could impact results in studies applying biological HPA probes to psychiatric populations. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758763      PMCID: PMC2824051          DOI: 10.1016/j.psyneuen.2009.08.007

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  40 in total

1.  Implicit and explicit memory for emotion-congruent information in clinical depression and anxiety.

Authors:  B P Bradley; K Mogg; R Williams
Journal:  Behav Res Ther       Date:  1995-09

2.  Integral as well as proportional adrenal responses to ACTH.

Authors:  M E Keller-Wood; J Shinsako; M F Dallman
Journal:  Am J Physiol       Date:  1983-07

3.  Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment.

Authors:  G C Curtis; J L Abelson; P W Gold
Journal:  Biol Psychiatry       Date:  1997-01-01       Impact factor: 13.382

4.  Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.

Authors:  C H Lammers; D Garcia-Borreguero; J Schmider; U Gotthardt; M Dettling; F Holsboer; I J Heuser
Journal:  Biol Psychiatry       Date:  1995-12-15       Impact factor: 13.382

5.  The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

Authors:  I Heuser; A Yassouridis; F Holsboer
Journal:  J Psychiatr Res       Date:  1994 Jul-Aug       Impact factor: 4.791

6.  A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.

Authors:  B J Carroll; M Feinberg; J F Greden; J Tarika; A A Albala; R F Haskett; N M James; Z Kronfol; N Lohr; M Steiner; J P de Vigne; E Young
Journal:  Arch Gen Psychiatry       Date:  1981-01

7.  Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model.

Authors:  J L Abelson; J G Weg; R M Nesse; G C Curtis
Journal:  Psychoneuroendocrinology       Date:  1996-05       Impact factor: 4.905

8.  Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients.

Authors:  E A Young; R F Haskett; L Grunhaus; A Pande; V M Weinberg; S J Watson; H Akil
Journal:  Arch Gen Psychiatry       Date:  1994-09

9.  Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.

Authors:  J L Abelson; G C Curtis
Journal:  Arch Gen Psychiatry       Date:  1996-04

10.  Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology.

Authors:  J L Abelson; R M Nesse; A I Vinik
Journal:  Biol Psychiatry       Date:  1994-07-15       Impact factor: 13.382

View more
  6 in total

1.  Brief cognitive intervention can modulate neuroendocrine stress responses to the Trier Social Stress Test: buffering effects of a compassionate goal orientation.

Authors:  James L Abelson; Thane M Erickson; Stefanie E Mayer; Jennifer Crocker; Hedieh Briggs; Nestor L Lopez-Duran; Israel Liberzon
Journal:  Psychoneuroendocrinology       Date:  2014-03-03       Impact factor: 4.905

2.  Plasma cortisol response cannot be classically conditioned in a taste-endocrine paradigm in humans.

Authors:  Liubov Petrakova; Karoline Boy; Marisa Kügler; Sven Benson; Harald Engler; Lars Möller; Manfred Schedlowski
Journal:  Psychopharmacology (Berl)       Date:  2017-08-13       Impact factor: 4.530

3.  HPA-Axis Activation as a Key Moderator of Childhood Trauma Exposure and Adolescent Mental Health.

Authors:  Kate R Kuhlman; Elisa G Geiss; Ivan Vargas; Nestor Lopez-Duran
Journal:  J Abnorm Child Psychol       Date:  2018-01

4.  The psychology of HPA axis activation: Examining subjective emotional distress and control in a phobic fear exposure model.

Authors:  Stefanie E Mayer; Michael Snodgrass; Israel Liberzon; Hedieh Briggs; George C Curtis; James L Abelson
Journal:  Psychoneuroendocrinology       Date:  2017-02-09       Impact factor: 4.905

Review 5.  Psychobiology of PTSD in the acute aftermath of trauma: Integrating research on coping, HPA function and sympathetic nervous system activity.

Authors:  Matthew C Morris; Uma Rao
Journal:  Asian J Psychiatr       Date:  2012-09-06

6.  Intravenous Corticotropin-releasing Hormone Administration Increases Esophageal Electrical Sensitivity in Healthy Individuals.

Authors:  Takahisa Yamasaki; Toshihiko Tomita; Mayu Takimoto; Takashi Kondo; Katsuyuki Tozawa; Yoshio Ohda; Tadayuki Oshima; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2017-10-30       Impact factor: 4.924

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.